Holen Sie sich die Stockscreener-App
21.59
1.46%
-0.32
Handel nachbörslich:
21.54
-0.05
-0.23%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt RARE?
Forum
Prognose
Aktiensplit
Ultragenyx Pharmaceutical Inc Aktie (RARE) Neueste Nachrichten
How The Ultragenyx Pharmaceutical (RARE) Investment Story Is Shifting With New Data And Street Views - Yahoo Finance
RARE Stock Edges Up On Priority Review For Gene Therapy In Rare Metabolic Disorder - Stocktwits
Ultragenyx Pharmaceutical Inc. $RARE Shares Acquired by BNP Paribas Financial Markets - MarketBeat
Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Rating Upgraded by Wall Street Zen - MarketBeat
Institutional Confidence in GTX-102 Fuels Optimism for Ultragenyx Pharmaceutical (RARE) - Insider Monkey
Ultragenyx EVP and chief medical officer Crombez sells $8,586 in shares - Investing.com Nigeria
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm - Morningstar
Ultragenyx (RARE) Down 13.6% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Ultragenyx to Participate at Goldman Sachs 47th Annual Global Healthcare Conference - The Manila Times
What to Know About This Fund's $5.4 Million Ultragenyx Purchase as Shares Slip 30% in One Year - AOL.com
Insider Sell: Howard Horn Sells Shares of Ultragenyx Pharmaceuti - GuruFocus
Ultragenyx CFO Horn sells $110,601 in company stock By Investing.com - Investing.com Australia
Insider Selling: Ultragenyx Pharmaceutical (NASDAQ:RARE) CFO Sells 4,653 Shares of Stock - MarketBeat
Ultragenyx CFO Horn sells $110,601 in company stock - Investing.com
Ultragenyx Pharmaceutical (RARE) CFO sells 4,653 common shares - Stock Titan
Jefferies Financial Group Inc. Takes $10.97 Million Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Blue Owl Capital Holdings LP Decreases Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Northwestern Mutual Wealth Management Co. Has $4.63 Million Stock Position in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Fideuram Intesa Sanpaolo Private Banking S.P.A. Makes New Investment in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
J.P. Morgan Maintains Ultragenyx Pharmaceutical(RARE.US) With Buy Rating, Cuts Target Price to $72 - Moomoo
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Fideuram Intesa Sanpaolo Private Banking S.P.A. Invests $1.41 Million in Ultragenyx Pharmaceutical Inc. $RARE - MarketBeat
Cantor Fitzgerald raises Ultragenyx stock price target on therapy outlook By Investing.com - Investing.com South Africa
RARE Maintained by Cantor Fitzgerald -- Price Target Raised to $96 - GuruFocus
Cantor Fitzgerald Issues Positive Forecast for Ultragenyx Pharmaceutical (NASDAQ:RARE) Stock Price - MarketBeat
Ultragenyx Pharmaceutical’s SWOT analysis: stock faces pivotal trial results By Investing.com - Investing.com South Africa
Cantor Fitzgerald raises Ultragenyx stock price target on therapy outlook - Investing.com
Ultragenyx Pharmaceutical’s SWOT analysis: stock faces pivotal trial results - Investing.com
Ultragenyx Earnings Call Balances Growth and Cash Burn - TipRanks
Ultragenyx Shareholders Approve Incentive Plan, Elect Directors - The Globe and Mail
Ultragenyx director Suliman Shehnaaz sells $144,188 in stock By Investing.com - Investing.com Nigeria
Ultragenyx Pharmaceutical stock (US74930A1043): Shareholders back incentive plan - AD HOC NEWS
Ultragenyx director Suliman Shehnaaz sells $144,188 in stock - Investing.com UK
Ultragenyx (RARE) director receives RSU and stock option grants in new Form 4 - Stock Titan
Ultragenyx (RARE) director sells shares and receives RSU and option awards - Stock Titan
Ultragenyx (RARE) director granted RSUs and stock options as compensation - Stock Titan
Ultragenyx (RARE) director receives RSU and stock option grants - Stock Titan
Ultragenyx (RARE) director Narachi receives RSU and option awards - Stock Titan
[Form 4] Ultragenyx Pharmaceutical Inc. Insider Trading Activity - Stock Titan
Ultragenyx (RARE) director Deborah Dunsire granted RSUs and new stock options - Stock Titan
[144] Ultragenyx Pharmaceutical Inc. SEC Filing - Stock Titan
Ultragenyx shareholders approve director elections and incentive plan at annual meeting - Investing.com Nigeria
0.05%
0.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):